Hervé Tilly Selected Research

Bleomycin (Blenoxane)

7/2015	Outcome of patients older than 60 years with classical Hodgkin lymphoma treated with front line ABVD chemotherapy: frequent pulmonary events suggest limiting the use of bleomycin in the elderly.
12/2014	Young patients with non-germinal center B-cell-like diffuse large B-cell lymphoma benefit from intensified chemotherapy with ACVBP plus rituximab compared with CHOP plus rituximab: analysis of data from the Groupe d'Etudes des Lymphomes de l'Adulte/lymphoma study association phase III trial LNH 03-2B.
3/2005	ACVBP versus CHOP plus radiotherapy for localized aggressive lymphoma.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Hervé Tilly Research Topics

Disease

45	Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse) 01/2023 - 01/2002
35	Lymphoma (Lymphomas) 02/2024 - 05/2002
30	Neoplasms (Cancer) 12/2023 - 02/2004
26	Follicular Lymphoma (Lymphoma, Small Cleaved Cell, Follicular) 02/2024 - 07/2008
23	B-Cell Lymphoma (Lymphoma, B Cell) 12/2023 - 06/2005
13	Non-Hodgkin Lymphoma (Lymphosarcoma) 12/2022 - 12/2003
8	Hodgkin Disease (Hodgkin's Disease) 01/2022 - 12/2007
7	Mantle-Cell Lymphoma (Lymphoma, Mantle Cell) 11/2023 - 01/2014
6	Infections 07/2022 - 05/2015
6	Disease Progression 01/2021 - 07/2008
6	Neutropenia 01/2018 - 11/2005
5	Residual Neoplasm 11/2023 - 01/2016
5	T-Cell Lymphoma (Lymphoma, T Cell) 01/2022 - 09/2010
5	Peripheral T-Cell Lymphoma (Lymphoma, T Cell, Peripheral) 01/2018 - 09/2010
3	Anaplastic Large-Cell Lymphoma (Ki 1 Lymphoma) 01/2017 - 09/2010
2	Marginal Zone B-Cell Lymphoma (MALT Lymphoma) 02/2024 - 06/2017
2	B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia) 12/2022 - 04/2018
2	Fatigue 01/2020 - 01/2019
2	Fever (Fevers) 08/2018 - 06/2005
2	Febrile Neutropenia 01/2018 - 05/2015
2	Sarcopenia 07/2014 - 04/2014
2	Hematologic Neoplasms (Hematological Malignancy) 11/2013 - 01/2005
2	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 05/2013 - 08/2011
1	Inflammation (Inflammations) 07/2023
1	Myocardial Ischemia (Ischemic Heart Diseases) 12/2022
1	Heart Valve Diseases (Valvular Heart Disease) 12/2022
1	Venous Thrombosis (Deep-Vein Thrombosis) 07/2022

Drug/Important Bio-Agent (IBA)

56	Rituximab (Mabthera)FDA Link 02/2024 - 01/2002
19	Doxorubicin (Adriamycin)FDA LinkGeneric 01/2023 - 01/2002
19	Cyclophosphamide (Cytoxan)FDA LinkGeneric 01/2023 - 01/2002
17	Prednisone (Sone)FDA LinkGeneric 01/2023 - 01/2002
17	Vincristine (Oncovin)FDA LinkGeneric 01/2023 - 01/2002
10	Lenalidomide (CC 5013)FDA Link 10/2022 - 08/2017
8	obinutuzumabIBA 01/2022 - 05/2012
8	DNA (Deoxyribonucleic Acid)IBA 10/2020 - 10/2012
6	polatuzumab vedotinIBA 01/2023 - 01/2019
6	Biomarkers (Surrogate Marker)IBA 12/2022 - 01/2016
6	Fluorodeoxyglucose F18 (Fludeoxyglucose F 18)FDA Link 01/2021 - 01/2012
6	Cytarabine (Cytosar-U)FDA LinkGeneric 01/2021 - 09/2010
5	Oxaliplatin (Eloxatin)FDA LinkGeneric 01/2022 - 11/2013
5	Cell-Free Nucleic AcidsIBA 10/2020 - 07/2015
5	Monoclonal AntibodiesIBA 08/2013 - 01/2002
4	Etoposide (VP 16)FDA LinkGeneric 11/2015 - 09/2010
3	L-Lactate Dehydrogenase (Lactate Dehydrogenase)IBA 12/2023 - 06/2005
3	AnthracyclinesIBA 12/2022 - 01/2012
3	Immunoglobulin Heavy Chains (Immunoglobulin Heavy Chain)IBA 12/2022 - 09/2013
3	Gemcitabine FDA Link 01/2022 - 11/2013
3	Bendamustine Hydrochloride FDA Link 01/2021 - 12/2016
3	Immunoconjugates (Immunoconjugate)IBA 01/2021 - 01/2016
3	RNA-Directed DNA Polymerase (Reverse Transcriptase)IBA 01/2020 - 04/2015
3	Melphalan (Alkeran)FDA LinkGeneric 11/2015 - 04/2011
3	Bleomycin (Blenoxane)FDA LinkGeneric 07/2015 - 03/2005
2	Chlorambucil (Leukeran)FDA Link 02/2024 - 06/2017
2	Enhancer of Zeste Homolog 2 ProteinIBA 11/2022 - 06/2015
2	Circulating Tumor DNAIBA 01/2022 - 01/2021
2	Indicators and Reagents (Reagents)IBA 01/2021 - 11/2017
2	Cisplatin (Platino)FDA LinkGeneric 01/2021 - 11/2020
2	Carboplatin (JM8)FDA LinkGeneric 01/2021 - 11/2020
2	tazemetostatIBA 11/2020 - 01/2020
2	Dexamethasone (Maxidex)FDA LinkGeneric 11/2020 - 02/2011
2	AntigensIBA 01/2017 - 01/2002
2	Brentuximab VedotinIBA 01/2017 - 03/2016
2	Histone Deacetylase InhibitorsIBA 01/2016 - 04/2015
2	Exportin 1 ProteinIBA 01/2016 - 01/2016
2	Carmustine (FIVB)FDA Link 11/2015 - 12/2014
2	Vindesine (Vindesin)IBA 12/2014 - 03/2005
2	Yttrium-90IBA 12/2014 - 04/2011
2	ibritumomab tiuxetan (Zevalin)FDA Link 12/2014 - 04/2011
2	Granulocyte Colony-Stimulating Factor (G-CSF)IBA 05/2013 - 11/2005
2	InterferonsIBA 08/2011 - 07/2008
2	Methotrexate (Mexate)FDA LinkGeneric 02/2011 - 09/2010
1	Immunoglobulins (Immunoglobulin)IBA 02/2024
1	T-Cell Antigen Receptors (T-Cell Receptor)IBA 02/2024
1	RNA (Ribonucleic Acid)IBA 02/2024
1	Prealbumin (Transthyretin)IBA 07/2023
1	Sodium-Potassium-Chloride SymportersIBA 01/2023
1	Complementary DNA (cDNA)IBA 12/2022
1	Agammaglobulinaemia Tyrosine KinaseIBA 03/2022
1	ibrutinibIBA 03/2022
1	SaltsIBA 03/2022
1	PlatinumIBA 03/2022
1	NivolumabIBA 01/2022
1	Arginine (L-Arginine)FDA Link 04/2021
1	Glycine (Aminoacetic Acid)FDA LinkGeneric 04/2021
1	FluorineIBA 04/2021

Therapy/Procedure

37	Drug Therapy (Chemotherapy) 12/2023 - 01/2002
35	Therapeutics 10/2022 - 05/2002
15	Stem Cell Transplantation 03/2022 - 05/2002
4	Transplantation 11/2020 - 05/2007
4	Induction Chemotherapy 11/2020 - 12/2003
3	Ligation 01/2020 - 04/2015
3	Salvage Therapy 01/2016 - 07/2008
3	BEAM regimen 11/2015 - 04/2011
2	Autologous Transplantation 01/2021 - 08/2011
2	Combination Drug Therapy (Combination Chemotherapy) 01/2021 - 01/2017
2	VAP-cyclo protocol 05/2013 - 01/2002
2	Radiotherapy 03/2007 - 03/2005
2	Chemoradiotherapy 03/2007 - 03/2005
1	Vascular Access Devices (Arterial Line) 07/2022
1	Catheters 07/2022